

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome
Details : RP101 is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dry Eye Syndromes.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 29, 2019
Lead Product(s) : Brivudine
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Cross Research S.A.
Deal Size : Inapplicable
Deal Type : Inapplicable
